Answers are grounded in this paper and cite their sources.
Eugenol is a widely used fish anesthetic, but its poor aqueous solubility, volatility, and environmental instability limit practical applications. This study compared the pharmacodynamic profiles and temporal stability of three eugenol formulations—raw dispersion, ethanol-solubilized solution, and a β-cyclodextrin (β-CD)/eugenol co-ground preparation—using juvenile Xenocypris davidi at 20 mg L⁻¹. Raw eugenol exhibited the longest induction time and lost efficacy entirely by 24 h post-preparation. Both the ethanol and β-CD formulations significantly accelerated induction, with no significant difference between them. However, the β-CD co-ground preparation produced a significantly prolonged recovery time and maintained consistent anesthetic performance over 24 h, whereas the ethanol formulation showed increased induction variability and the raw formulation failed completely. These results indicate that ethanol-solubilized eugenol is suitable for brief procedures requiring rapid recovery, whereas the β-CD co-ground preparation exhibited greater functional stability under the tested conditions.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: